SCHEMBL3824010

SCHEMBL3824010

CC(C#N)(COc1ccc(-n2ccnc2)cc1)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 3/20 0.45
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CYP2D6 P10635 8/20 0.43
CYP3A4 P08684 7/20 0.43
PORCN Q9H237 1/20 0.43
CYP2C9 P11712 7/20 0.43
CYP1A2 P05177 4/20 0.43
CYP2C19 P33261 3/20 0.43
CYP19A1 P11511 1/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPK1 P28482 1/20 0.42
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3819552 0.83 CYP1A2 (0.43) CYP2D6CYP2C9CYP1A2CYP2C19LMNA
SCHEMBL3817722 0.80 MAPT (0.43) ALDH1A1MAPTMAPK1HPGD
SCHEMBL3819295 0.80 AR (0.48) CA1CA2CYP3A4CYP1A2CYP2C19
SCHEMBL3820055 0.80 ALDH1A1 (0.48) CYP3A4CYP1A2CYP2C19ALDH1A1HTT
SCHEMBL3815007 0.79 AR (0.44) CYP3A4CYP1A2CYP2C19ALDH1A1MAPK1
SCHEMBL3814032 0.78 AR (0.33) CYP3A4CYP1A2CYP2C19CYP19A1LMNA
SCHEMBL3815985 0.77 LIPE (0.41) ALDH1A1MAPTMAPK1
SCHEMBL3815729 0.77 HPGD (0.51) LMNAALDH1A1MAPTHTTNPSR1
SCHEMBL3817855 0.76 CYP1A2 (0.42) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL3813194 0.76 RAB9A (0.46) CYP2D6CYP2C9CYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513802-B1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2009-08-19 EP claimed
US-7368479-B2 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION, INC. (US) 2008-05-06 US claimed
US-20050234125-A1 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION AG (CH) 2005-10-20 US claimed
EP-1513802-A1 ALPHA-SULFONYLAMINO-ACETONITRILES Syngenta Participations AG (CH) 2005-03-16 EP claimed
WO-2004000797-A1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2003-12-31 WO claimed
US-7368479-B2 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION, INC. (US) 2008-05-06 US disclosed
US-20050234125-A1 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION AG (CH) 2005-10-20 US disclosed
EP-1513802-A1 ALPHA-SULFONYLAMINO-ACETONITRILES Syngenta Participations AG (CH) 2005-03-16 EP disclosed
WO-2004000797-A1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234125-A1 Alpha-sulfonylamino-acetonitriles C3AR1, C1S, C5 ADRB1 28/4885CA1 3613/4885CA2 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.